# CLEVELAND CLINIC LERNER COM-CWRU: Bone marrow-derived myeloid cell dysregulation in malignant progression of glioma

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | CLEVELAND CLINIC LERNER COM-CWRU |
| Location | CLEVELAND, OH |
| Project | Bone marrow-derived myeloid cell dysregulation in malignant progression of glioma |
| Project number | 7R01NS127984-04 |
| Mechanism | R01 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $486,234 |
| Awarded | 2026-09-11 |
| Project period | 2023-07-15 to 2028-05-31 |
| UEI | M5QFLTCTSQN6 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11576103). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.